Literature DB >> 11289722

Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.

K Kyo1, T Muto, H Nagawa, G M Lathrop, Y Nakamura.   

Abstract

Ulcerative colitis (UC) and Crohn's disease (CD), the major forms of inflammatory bowel diseases (IBDs). are multifactorial disorders of unknown etiology. We reported a possible association of rare variable number of tandem repeat (VNTR) alleles of the "MUC3" gene with a susceptibility to UC. However, an entire structure of "MUC3" is still unknown because the long stretches of tandem repeats in this "gene" make its cloning extraordinarily difficult. In this study, we report evidence that "MUC3" consists of two genes, MUC3A and MUC3B, both of which encode membrane-bound mucins with two epidermal growth factor-like motifs, and we describe the complete 3'-terminal structures of these two genes. We have also analyzed the single nucleotide polymorphisms (SNPs) in the exonic sequences of the 3' portions of these two genes to investigate whether sequence variations in these regions can cause person-to-person differences in the susceptibility to IBDs, and report here that non-synonymous SNPs of MUC3A, involving a tyrosine residue with a proposed role in cell signaling, may confer genetic predisposition to CD (P = 0.0132). Our findings suggest that variants of MUC3A may be involved in the occurrence of UC and CD in distinct manners.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289722     DOI: 10.1007/s100380170118

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

Review 1.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

2.  Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Aritoshi Iida; Yoshihiro Onouchi; Akira Hata; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-10-19       Impact factor: 3.172

Review 3.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

4.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

5.  Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

Authors:  Christoph Moehle; Nikolaus Ackermann; Thomas Langmann; Charalampos Aslanidis; Alexander Kel; Olga Kel-Margoulis; Anna Schmitz-Madry; Alexandra Zahn; Wolfgang Stremmel; Gerd Schmitz
Journal:  J Mol Med (Berl)       Date:  2006-10-21       Impact factor: 4.599

6.  Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon.

Authors:  Shantibhusan Senapati; Samuel B Ho; Poonam Sharma; Srustidhar Das; Subhankar Chakraborty; Sukhwinder Kaur; Gloria Niehans; Surinder K Batra
Journal:  J Clin Pathol       Date:  2010-08       Impact factor: 3.411

7.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

8.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro.

Authors:  D R Mack; S Ahrne; L Hyde; S Wei; M A Hollingsworth
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  IBD candidate genes and intestinal barrier regulation.

Authors:  Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

Review 10.  Crohn's disease: an immune deficiency state.

Authors:  Daniel J B Marks; Farooq Z Rahman; Gavin W Sewell; Anthony W Segal
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.